18 results
8-K
EX-10.1
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
5:01pm
;
(vii) any material labor difficulties or, to the Company’s Knowledge, labor union organizing activities with respect to employees of the Company
S-3
EX-1.2
GLUE
Monte Rosa Therapeutics Inc
1 Jul 22
Shelf registration
5:01pm
” or “blocked person”), the United Nations Security Council (“UNSC”), the European Union, Her Majesty’s Treasury (“HMT”) or other relevant sanctions
10-K
2021 FY
GLUE
Monte Rosa Therapeutics Inc
29 Mar 22
Annual report
4:15pm
. For example, in the European Union, or EU, pricing and reimbursement of pharmaceutical products are regulated at a national level under the individual … and similar healthcare laws and regulations in the European Union and other jurisdictions, such, such as anti-kickback and false claims laws, which may apply
10-Q
w0vyog
12 Aug 21
Quarterly report
4:22pm
424B4
b7x2l6lal43bxt3y
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
l5w57iu
9 Jun 21
IPO registration (amended)
4:51pm
S-1
EX-10.19
07b9tm
4 Jun 21
IPO registration
9:07am
S-1
EX-10.18
c96tnt
4 Jun 21
IPO registration
9:07am
S-1
654c8r
4 Jun 21
IPO registration
9:07am
DRS/A
v4gz qqpx8
21 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
uczrg z9wnv7
30 Apr 21
Draft registration statement (amended)
12:00am
DRS
EX-10.18
mrjzb 5yk1fotrb
19 Apr 21
Draft registration statement
12:00am
DRS
6cc6xb 6cl0
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next